On Invalid Date, Natera (NASDAQ: NTRA) reported Q2 2023 earnings per share (EPS) of -$0.97, up 35.33% year over year. Total Natera earnings for the quarter were -$110.80 million. In the same quarter last year, Natera's earnings per share (EPS) was -$1.50.
On Invalid Date, Natera (NASDAQ: NTRA) reported Q2 2023 revenue of $261.40 million up 31.89% year over year. In the same quarter last year, Natera's revenue was $198.20 million.
What was NTRA's revenue growth in the past year?
As of Q3 2023, Natera's revenue has grown 28.69% year over year. This is 26.78 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 1.91%. Natera's revenue in the past year totalled $931.05 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.